Paris, January 11, 2022 – Capgemini announced today that it has been recognized by Frost & Sullivan with the 2021 Company of the Year Award for its work in digital transformation services in the life sciences industry. Capgemini received this accolade for its commitment to innovation, end-to-end capabilities, and the value behind its industry-leading solutions.
Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in customer value and market penetration.
According to Pavel Zhebrouski, Best Practices Research analyst at Frost & Sullivan, “Capgemini provides its groundbreaking, intelligent industry end-to-end capabilities to address the challenges across the life sciences industry. Capgemini’s mission includes supporting clients while becoming a strategic scaling-up partner through its breadth, depth, and wealth of capabilities.”
Capgemini’s comprehensive capabilities cover every crucial aspect for life sciences clients, including research and development activities with drug discovery powered by data and AI; AI-powered intelligent clinical trials for optimization of design, trial management and operation; and the move to intelligent manufacturing, intelligent supply chain, and connected health. On top of that, Capgemini develops comprehensive regulatory-compliance solutions for the life sciences industry.
Frost & Sullivan highlighted Capgemini’s industry-leading intelligent solutions and its wide-ranging portfolio of vertical-specific partnerships and in-house tools, which enable the rapid design and development of customized data-driven solutions that optimize the value chain — from strategy to implementation.
“This recognition validates Capgemini’s commitment to the life sciences industry. Our strategy is focused on our ability to accompany clients to accelerate time to care, scale up innovation, and optimize their value chain by leveraging the Group’s capabilities to deliver customized data-driven solutions,” said Olivier Zitoun, Global Life Sciences Industry Lead at Capgemini.
Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
Capgemini is a global leader in partnering with companies to transform and manage their business by harnessing the power of technology. The Group is guided everyday by its purpose of unleashing human energy through technology for an inclusive and sustainable future. It is a responsible and diverse organization of over 300,000 team members in nearly 50 countries. With its strong 50-year heritage and deep industry expertise, Capgemini is trusted by its clients to address the entire breadth of their business needs, from strategy and design to operations, fueled by the fast evolving and innovative world of cloud, data, AI, connectivity, software, digital engineering and platforms. The Group reported in 2020 global revenues of €16 billion.
Get The Future You Want | www.capgemini.com